ONI
Kamil Sumara, MBA, is an experienced Delivery Manager and Business Architect currently leading a Lead-to-Cash transformation initiative at Techtorch, specializing in Salesforce implementations for private equity in Ireland. With a robust background as an Enterprise Architect and Project/Program Manager at PineTrie, Kamil has conducted IT audits and optimization assessments across various sectors. Previous roles include managing cybersecurity and digital transformation portfolios at EY, overseeing E-Commerce projects at LOT Polish Airlines, and serving in leadership positions at Capgemini, where responsibilities encompassed SAP project management and team leadership. Kamil holds an Executive MBA from Hult International Business School and multiple degrees in Management and Marketing from SGH Warsaw School of Economics.
This person is not in any offices
ONI
7 followers
ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal. The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard. ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.